HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-DEC-19 6LN1 TITLE A NATURAL INHIBITOR OF DYRK1A FOR TREATMENT OF DIABETES MELLITUS CAVEAT 6LN1 LEU B 314 HAS WRONG CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE COMPND 3 1A; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: DUAL SPECIFICITY YAK1-RELATED KINASE,HP86,PROTEIN KINASE COMPND 6 MINIBRAIN HOMOLOG,HMNB; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DYRK1A, DYRK, MNB, MNBH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTI-DIABETIC ACTIVITY, DESMETHYLBELLIDIFOLIN, DYRK1A, INHIBITOR, KEYWDS 2 TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,L.X.CHEN,M.Z.ZHENG,Q.Z.ZHANG,C.L.ZHANG,C.R.WU,K.Y.YANG,Z.R.SONG, AUTHOR 2 Q.Q.WANG,C.LI,Y.R.ZHOU,J.C.CHEN REVDAT 2 22-NOV-23 6LN1 1 REMARK REVDAT 1 06-OCT-21 6LN1 0 JRNL AUTH M.ZHENG,Q.ZHANG,C.ZHANG,C.WU,K.YANG,Z.SONG,Q.WANG,C.LI, JRNL AUTH 2 Y.ZHOU,J.CHEN,H.LI,L.CHEN JRNL TITL A NATURAL DYRK1A INHIBITOR AS A POTENTIAL STIMULATOR FOR JRNL TITL 2 BETA-CELL PROLIFERATION IN DIABETES. JRNL REF CLIN TRANSL MED V. 11 E494 2021 JRNL REFN ISSN 2001-1326 JRNL PMID 34323401 JRNL DOI 10.1002/CTM2.494 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 25832 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.9740 - 6.4998 1.00 1754 145 0.1909 0.2468 REMARK 3 2 6.4998 - 5.1609 1.00 1714 147 0.2231 0.2915 REMARK 3 3 5.1609 - 4.5090 1.00 1704 145 0.1843 0.2665 REMARK 3 4 4.5090 - 4.0970 1.00 1708 144 0.1888 0.2561 REMARK 3 5 4.0970 - 3.8035 1.00 1699 144 0.1975 0.2716 REMARK 3 6 3.8035 - 3.5793 1.00 1707 144 0.2153 0.2392 REMARK 3 7 3.5793 - 3.4001 1.00 1679 139 0.2263 0.3139 REMARK 3 8 3.4001 - 3.2521 1.00 1695 143 0.2298 0.2655 REMARK 3 9 3.2521 - 3.1269 1.00 1707 147 0.2286 0.3188 REMARK 3 10 3.1269 - 3.0190 1.00 1691 141 0.2269 0.2913 REMARK 3 11 3.0190 - 2.9247 1.00 1693 148 0.2558 0.2804 REMARK 3 12 2.9247 - 2.8411 1.00 1672 145 0.2669 0.3817 REMARK 3 13 2.8411 - 2.7663 1.00 1691 139 0.2826 0.3418 REMARK 3 14 2.7663 - 2.6990 1.00 1703 144 0.2969 0.3456 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LN1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1300015087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 R CDTE 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25854 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.699 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.19600 REMARK 200 R SYM FOR SHELL (I) : 1.36500 REMARK 200 FOR SHELL : 1.520 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YLK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS, 17% PEG 1500, 30% REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.11900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 46.11900 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.11900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 407A REMARK 465 LYS A 407B REMARK 465 ASP A 407C REMARK 465 GLY A 407D REMARK 465 LYS A 407E REMARK 465 VAL B 135 REMARK 465 TYR B 136 REMARK 465 ASN B 137 REMARK 465 ASP B 138 REMARK 465 GLY B 139 REMARK 465 ASP B 214 REMARK 465 GLY B 315 REMARK 465 GLN B 316 REMARK 465 ARG B 317 REMARK 465 ILE B 318 REMARK 465 THR B 407A REMARK 465 LYS B 407B REMARK 465 ASP B 407C REMARK 465 GLY B 407D REMARK 465 LYS B 407E REMARK 465 LYS B 480 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 PTR A 321 REMARK 475 PTR B 321 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 250 CZ REMARK 480 ARG B 250 CZ REMARK 480 ARG B 458 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO B 470 CD1 LEU B 474 1.34 REMARK 500 O TYR B 140 CD1 ILE B 148 1.45 REMARK 500 ND2 ASN B 151 O ASP B 162 1.52 REMARK 500 CB TYR B 145 CE LYS B 191 1.61 REMARK 500 O ARG B 412 O PHE B 413 1.74 REMARK 500 O ASN B 144 NZ LYS B 191 1.89 REMARK 500 CD2 TYR B 145 NZ LYS B 191 1.93 REMARK 500 CZ PHE A 413 O HOH B 605 1.96 REMARK 500 ND2 ASN B 151 CA SER B 163 1.98 REMARK 500 OD1 ASP B 142 N ASN B 144 1.99 REMARK 500 O THR B 445 N ASP B 448 2.03 REMARK 500 C TYR B 140 CD1 ILE B 148 2.06 REMARK 500 CD2 TYR B 145 CE LYS B 191 2.08 REMARK 500 CG TYR B 145 CE LYS B 191 2.08 REMARK 500 CB ASN A 211 O HOH A 626 2.09 REMARK 500 O HIS B 285 OG SER B 311 2.10 REMARK 500 C PRO B 470 CD1 LEU B 474 2.13 REMARK 500 ND2 ASN B 151 C ASP B 162 2.15 REMARK 500 OD1 ASP B 157 NH2 ARG B 179 2.16 REMARK 500 O GLY B 443 OD2 ASP B 448 2.18 REMARK 500 O ASN B 144 CE LYS B 191 2.18 REMARK 500 ND2 ASN B 151 CB SER B 163 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD1 TYR A 319 CB ASP B 157 3655 1.78 REMARK 500 CE1 TYR A 319 CB ASP B 157 3655 2.16 REMARK 500 NZ LYS A 193 OE1 GLU B 181 3655 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 214 C THR A 215 N -0.441 REMARK 500 ARG A 317 C ILE A 318 N -0.194 REMARK 500 GLN A 320 C PTR A 321 N -0.145 REMARK 500 ARG A 437 CG ARG A 437 CD 0.155 REMARK 500 GLN B 313 C LEU B 314 N 0.194 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 215 CB - CA - C ANGL. DEV. = -29.1 DEGREES REMARK 500 ARG A 317 O - C - N ANGL. DEV. = -13.8 DEGREES REMARK 500 ALA A 391 CB - CA - C ANGL. DEV. = -9.4 DEGREES REMARK 500 ASP B 142 C - N - CA ANGL. DEV. = -34.5 DEGREES REMARK 500 ASP B 142 N - CA - CB ANGL. DEV. = -39.3 DEGREES REMARK 500 PRO B 298 C - N - CD ANGL. DEV. = 13.2 DEGREES REMARK 500 ASP B 307 CB - CA - C ANGL. DEV. = -13.8 DEGREES REMARK 500 ASP B 307 N - CA - C ANGL. DEV. = 23.0 DEGREES REMARK 500 LEU B 314 CB - CA - C ANGL. DEV. = 18.1 DEGREES REMARK 500 GLU B 414 N - CA - C ANGL. DEV. = -33.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 142 -158.97 -100.91 REMARK 500 ARG A 158 -43.56 -136.63 REMARK 500 LYS A 218 -7.53 -52.45 REMARK 500 SER A 242 -156.40 -110.18 REMARK 500 SER A 282 69.32 32.29 REMARK 500 CYS A 286 -0.24 80.94 REMARK 500 ASP A 287 46.35 -153.77 REMARK 500 ASP A 307 76.45 62.10 REMARK 500 ILE A 318 93.24 128.74 REMARK 500 GLN A 323 147.87 66.77 REMARK 500 ASP A 339 -158.97 -136.86 REMARK 500 PRO A 381 142.63 -36.89 REMARK 500 PRO A 389 -36.16 -32.17 REMARK 500 ASP B 142 -154.16 -132.75 REMARK 500 GLU B 153 140.60 -39.29 REMARK 500 MET B 156 28.30 34.00 REMARK 500 ASP B 157 -4.17 33.06 REMARK 500 ASP B 162 -60.23 -95.40 REMARK 500 SER B 163 170.44 177.07 REMARK 500 MET B 210 -70.45 -63.68 REMARK 500 ASN B 211 -5.70 -57.56 REMARK 500 LYS B 218 -13.43 -42.48 REMARK 500 TYR B 219 41.58 -101.02 REMARK 500 GLU B 239 155.12 -46.74 REMARK 500 SER B 242 -158.37 -90.32 REMARK 500 TYR B 243 155.83 -48.75 REMARK 500 ASN B 253 46.41 35.44 REMARK 500 SER B 258 139.07 -35.09 REMARK 500 ASP B 287 28.07 -154.81 REMARK 500 LYS B 289 160.96 175.25 REMARK 500 PRO B 298 17.70 -62.48 REMARK 500 PHE B 308 41.72 -78.78 REMARK 500 GLN B 323 164.72 91.42 REMARK 500 LYS B 406 -132.40 -67.72 REMARK 500 PHE B 413 -160.35 23.66 REMARK 500 ARG B 438 30.20 -96.66 REMARK 500 ILE B 468 151.05 -41.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 215 GLU A 216 -146.01 REMARK 500 ARG A 317 ILE A 318 128.77 REMARK 500 ILE A 318 TYR A 319 99.47 REMARK 500 TYR A 319 GLN A 320 149.85 REMARK 500 TYR B 140 ASP B 141 -140.65 REMARK 500 ARG B 412 PHE B 413 -144.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG A 317 12.94 REMARK 500 REMARK 500 REMARK: NULL DBREF 6LN1 A 135 480 UNP Q13627 DYR1A_HUMAN 135 480 DBREF 6LN1 B 135 480 UNP Q13627 DYR1A_HUMAN 135 480 SEQADV 6LN1 PHE A 413 UNP Q13627 INSERTION SEQADV 6LN1 PHE B 413 UNP Q13627 INSERTION SEQRES 1 A 347 VAL TYR ASN ASP GLY TYR ASP ASP ASP ASN TYR ASP TYR SEQRES 2 A 347 ILE VAL LYS ASN GLY GLU LYS TRP MET ASP ARG TYR GLU SEQRES 3 A 347 ILE ASP SER LEU ILE GLY LYS GLY SER PHE GLY GLN VAL SEQRES 4 A 347 VAL LYS ALA TYR ASP ARG VAL GLU GLN GLU TRP VAL ALA SEQRES 5 A 347 ILE LYS ILE ILE LYS ASN LYS LYS ALA PHE LEU ASN GLN SEQRES 6 A 347 ALA GLN ILE GLU VAL ARG LEU LEU GLU LEU MET ASN LYS SEQRES 7 A 347 HIS ASP THR GLU MET LYS TYR TYR ILE VAL HIS LEU LYS SEQRES 8 A 347 ARG HIS PHE MET PHE ARG ASN HIS LEU CYS LEU VAL PHE SEQRES 9 A 347 GLU MET LEU SER TYR ASN LEU TYR ASP LEU LEU ARG ASN SEQRES 10 A 347 THR ASN PHE ARG GLY VAL SER LEU ASN LEU THR ARG LYS SEQRES 11 A 347 PHE ALA GLN GLN MET CYS THR ALA LEU LEU PHE LEU ALA SEQRES 12 A 347 THR PRO GLU LEU SER ILE ILE HIS CYS ASP LEU LYS PRO SEQRES 13 A 347 GLU ASN ILE LEU LEU CYS ASN PRO LYS ARG SER ALA ILE SEQRES 14 A 347 LYS ILE VAL ASP PHE GLY SER SER CYS GLN LEU GLY GLN SEQRES 15 A 347 ARG ILE TYR GLN PTR ILE GLN SER ARG PHE TYR ARG SER SEQRES 16 A 347 PRO GLU VAL LEU LEU GLY MET PRO TYR ASP LEU ALA ILE SEQRES 17 A 347 ASP MET TRP SER LEU GLY CYS ILE LEU VAL GLU MET HIS SEQRES 18 A 347 THR GLY GLU PRO LEU PHE SER GLY ALA ASN GLU VAL ASP SEQRES 19 A 347 GLN MET ASN LYS ILE VAL GLU VAL LEU GLY ILE PRO PRO SEQRES 20 A 347 ALA HIS ILE LEU ASP GLN ALA PRO LYS ALA ARG LYS PHE SEQRES 21 A 347 PHE GLU LYS LEU PRO ASP GLY THR TRP ASN LEU LYS LYS SEQRES 22 A 347 THR LYS ASP GLY LYS ARG PHE GLU TYR LYS PRO PRO GLY SEQRES 23 A 347 THR ARG LYS LEU HIS ASN ILE LEU GLY VAL GLU THR GLY SEQRES 24 A 347 GLY PRO GLY GLY ARG ARG ALA GLY GLU SER GLY HIS THR SEQRES 25 A 347 VAL ALA ASP TYR LEU LYS PHE LYS ASP LEU ILE LEU ARG SEQRES 26 A 347 MET LEU ASP TYR ASP PRO LYS THR ARG ILE GLN PRO TYR SEQRES 27 A 347 TYR ALA LEU GLN HIS SER PHE PHE LYS SEQRES 1 B 347 VAL TYR ASN ASP GLY TYR ASP ASP ASP ASN TYR ASP TYR SEQRES 2 B 347 ILE VAL LYS ASN GLY GLU LYS TRP MET ASP ARG TYR GLU SEQRES 3 B 347 ILE ASP SER LEU ILE GLY LYS GLY SER PHE GLY GLN VAL SEQRES 4 B 347 VAL LYS ALA TYR ASP ARG VAL GLU GLN GLU TRP VAL ALA SEQRES 5 B 347 ILE LYS ILE ILE LYS ASN LYS LYS ALA PHE LEU ASN GLN SEQRES 6 B 347 ALA GLN ILE GLU VAL ARG LEU LEU GLU LEU MET ASN LYS SEQRES 7 B 347 HIS ASP THR GLU MET LYS TYR TYR ILE VAL HIS LEU LYS SEQRES 8 B 347 ARG HIS PHE MET PHE ARG ASN HIS LEU CYS LEU VAL PHE SEQRES 9 B 347 GLU MET LEU SER TYR ASN LEU TYR ASP LEU LEU ARG ASN SEQRES 10 B 347 THR ASN PHE ARG GLY VAL SER LEU ASN LEU THR ARG LYS SEQRES 11 B 347 PHE ALA GLN GLN MET CYS THR ALA LEU LEU PHE LEU ALA SEQRES 12 B 347 THR PRO GLU LEU SER ILE ILE HIS CYS ASP LEU LYS PRO SEQRES 13 B 347 GLU ASN ILE LEU LEU CYS ASN PRO LYS ARG SER ALA ILE SEQRES 14 B 347 LYS ILE VAL ASP PHE GLY SER SER CYS GLN LEU GLY GLN SEQRES 15 B 347 ARG ILE TYR GLN PTR ILE GLN SER ARG PHE TYR ARG SER SEQRES 16 B 347 PRO GLU VAL LEU LEU GLY MET PRO TYR ASP LEU ALA ILE SEQRES 17 B 347 ASP MET TRP SER LEU GLY CYS ILE LEU VAL GLU MET HIS SEQRES 18 B 347 THR GLY GLU PRO LEU PHE SER GLY ALA ASN GLU VAL ASP SEQRES 19 B 347 GLN MET ASN LYS ILE VAL GLU VAL LEU GLY ILE PRO PRO SEQRES 20 B 347 ALA HIS ILE LEU ASP GLN ALA PRO LYS ALA ARG LYS PHE SEQRES 21 B 347 PHE GLU LYS LEU PRO ASP GLY THR TRP ASN LEU LYS LYS SEQRES 22 B 347 THR LYS ASP GLY LYS ARG PHE GLU TYR LYS PRO PRO GLY SEQRES 23 B 347 THR ARG LYS LEU HIS ASN ILE LEU GLY VAL GLU THR GLY SEQRES 24 B 347 GLY PRO GLY GLY ARG ARG ALA GLY GLU SER GLY HIS THR SEQRES 25 B 347 VAL ALA ASP TYR LEU LYS PHE LYS ASP LEU ILE LEU ARG SEQRES 26 B 347 MET LEU ASP TYR ASP PRO LYS THR ARG ILE GLN PRO TYR SEQRES 27 B 347 TYR ALA LEU GLN HIS SER PHE PHE LYS MODRES 6LN1 PTR A 321 TYR MODIFIED RESIDUE MODRES 6LN1 PTR B 321 TYR MODIFIED RESIDUE HET PTR A 321 16 HET PTR B 321 16 HET EKU A 501 27 HET EKU B 501 27 HETNAM PTR O-PHOSPHOTYROSINE HETNAM EKU 1,3,5,8-TETRAKIS(OXIDANYL)XANTHEN-9-ONE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 EKU 2(C13 H8 O6) FORMUL 5 HOH *44(H2 O) HELIX 1 AA1 TYR A 136 TYR A 140 5 5 HELIX 2 AA2 LYS A 193 ASN A 211 1 19 HELIX 3 AA3 THR A 215 ILE A 221 5 7 HELIX 4 AA4 ASN A 244 ASN A 251 1 8 HELIX 5 AA5 SER A 258 THR A 278 1 21 HELIX 6 AA6 LYS A 289 GLU A 291 5 3 HELIX 7 AA7 SER A 324 ARG A 328 5 5 HELIX 8 AA8 SER A 329 LEU A 334 1 6 HELIX 9 AA9 LEU A 340 GLY A 357 1 18 HELIX 10 AB1 ASN A 365 GLY A 378 1 14 HELIX 11 AB2 PRO A 381 ASP A 386 1 6 HELIX 12 AB3 LYS A 390 LYS A 393 5 4 HELIX 13 AB4 LYS A 422 GLY A 428 1 7 HELIX 14 AB5 GLY A 433 ARG A 437 5 5 HELIX 15 AB6 THR A 445 LEU A 460 1 16 HELIX 16 AB7 GLN A 469 LEU A 474 1 6 HELIX 17 AB8 LYS B 193 LYS B 212 1 20 HELIX 18 AB9 THR B 215 ILE B 221 5 7 HELIX 19 AC1 ASN B 244 ASN B 251 1 8 HELIX 20 AC2 SER B 258 THR B 278 1 21 HELIX 21 AC3 LYS B 289 GLU B 291 5 3 HELIX 22 AC4 SER B 329 GLY B 335 1 7 HELIX 23 AC5 LEU B 340 GLY B 357 1 18 HELIX 24 AC6 ASN B 365 GLY B 378 1 14 HELIX 25 AC7 PRO B 381 ASP B 386 1 6 HELIX 26 AC8 LYS B 390 LYS B 393 5 4 HELIX 27 AC9 LYS B 422 GLY B 428 1 7 HELIX 28 AD1 GLY B 433 ARG B 437 5 5 HELIX 29 AD2 THR B 445 LEU B 460 1 16 HELIX 30 AD3 GLN B 469 LEU B 474 1 6 SHEET 1 AA1 6 LYS A 154 TRP A 155 0 SHEET 2 AA1 6 TYR A 159 GLY A 168 -1 O TYR A 159 N TRP A 155 SHEET 3 AA1 6 GLY A 171 ASP A 178 -1 O VAL A 173 N ILE A 165 SHEET 4 AA1 6 GLU A 183 ILE A 190 -1 O VAL A 185 N ALA A 176 SHEET 5 AA1 6 HIS A 233 GLU A 239 -1 O PHE A 238 N ALA A 186 SHEET 6 AA1 6 LEU A 224 PHE A 230 -1 N ARG A 226 O VAL A 237 SHEET 1 AA2 2 ILE A 283 ILE A 284 0 SHEET 2 AA2 2 CYS A 312 GLN A 313 -1 O CYS A 312 N ILE A 284 SHEET 1 AA3 2 ILE A 293 LEU A 295 0 SHEET 2 AA3 2 ILE A 303 ILE A 305 -1 O LYS A 304 N LEU A 294 SHEET 1 AA4 2 PHE A 395 LYS A 397 0 SHEET 2 AA4 2 TRP A 403 LEU A 405 -1 O ASN A 404 N GLU A 396 SHEET 1 AA5 6 LYS B 154 TRP B 155 0 SHEET 2 AA5 6 TYR B 159 LYS B 167 -1 O TYR B 159 N TRP B 155 SHEET 3 AA5 6 GLY B 171 ASP B 178 -1 O VAL B 173 N ILE B 165 SHEET 4 AA5 6 GLU B 183 ILE B 190 -1 O VAL B 185 N ALA B 176 SHEET 5 AA5 6 HIS B 233 GLU B 239 -1 O LEU B 234 N ILE B 190 SHEET 6 AA5 6 LEU B 224 PHE B 230 -1 N ARG B 226 O VAL B 237 SHEET 1 AA6 2 ILE B 293 LEU B 295 0 SHEET 2 AA6 2 ILE B 303 ILE B 305 -1 O LYS B 304 N LEU B 294 SHEET 1 AA7 2 PHE B 395 LYS B 397 0 SHEET 2 AA7 2 TRP B 403 LEU B 405 -1 O ASN B 404 N GLU B 396 LINK C GLN A 320 N PTR A 321 1555 1555 1.19 LINK C PTR A 321 N ILE A 322 1555 1555 1.32 LINK C GLN B 320 N PTR B 321 1555 1555 1.32 LINK C PTR B 321 N ILE B 322 1555 1555 1.32 CRYST1 133.467 133.467 92.238 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007492 0.004326 0.000000 0.00000 SCALE2 0.000000 0.008652 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010842 0.00000